1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N0509
    Astilbin

    落新妇苷

    Inhibitor 99.97%
    Astilbin 是一种黄酮类化合物,可增强 NRF2 活化。Astilbin 还抑制 TNF-α 表达和 NF-κB 活化。
    Astilbin
  • HY-Y1362
    Ethyl pyruvate

    丙酮酸乙酯

    Inhibitor 99.87%
    Ethyl pyruvate 是内源性代谢物丙酮酸的简单衍生物。Ethyl pyruvate 是一种 HMGB1 释放抑制剂。Ethyl pyruvate 可通过自噬 (autophagy) 诱导细胞凋亡 (apoptosis)。Ethyl pyruvate 具有抗炎、抗氧化和抗肿瘤活性。Ethyl pyruvate 可用于神经退行性疾病如阿尔茨海默病和帕金森病的研究。
    Ethyl pyruvate
  • HY-W050154
    Kojic acid

    曲酸

    Inhibitor 99.99%
    Kojic acid 是由 Aspergillus oryzae 产生的物质,具有口服有效性,也可被透皮吸收。Kojic acid 具有抗衰老、抗线虫、抗菌、抗氧化、抗炎等多种生物活性。Kojic acid 是Tyrosinase抑制剂,对 Mushroon Tyrosinase IC50 为 182.7 μM。Kojic acid 通过捕获与酪氨酸酶活性位点结合的铜离子防止其激活来阻止黑色素产生。Kojic acid 对人角质形成细胞中 NF-κBp21 信号通路具有抑制作用。Kojic acid 衍生物具有抗肿瘤活性。
    Kojic acid
  • HY-109017
    Vamorolone

    地塞米松EP杂质E

    Inhibitor 99.10%
    Vamorolone (VBP15) 是首创的,具有口服活性的解离性类固醇 (dissociative steroidal) 抗炎剂和膜稳定剂。Vamorolone 改善肌营养不良,无副作用。Vamorolone 抑制 (NF-κB) 抑制作用,并降低了激素的影响。
    Vamorolone
  • HY-W011474
    Geranylgeraniol

    香叶基香叶醇;基牻牛儿醇

    Inhibitor 99.18%
    Geranylgeraniol 是一种口服有效的维生素 K2 亚型,是甲戊酸途径 (mevalonate pathway) 的中间体。Geranylgeraniol 靶向 NF-kB 信号通路,可在动物模型中减轻脂多糖 (LPS) 诱导的小胶质细胞炎症。
    Geranylgeraniol
  • HY-B0185A
    Lidocaine hydrochloride

    盐酸利多卡因

    Inhibitor 99.96%
    Lidocaine (Lignocaine) hydrochloride 抑制涉及复杂电压和依赖性的钠通道 (sodium channels)。Lidocaine hydrochloride 通过调节 miR-145 表达和进一步抑制 MEK/ERKNF-κB 信号通路来减少胃癌细胞的生长,迁移和侵袭。Lidocaine 是一种酰胺衍生物,是一种研究室性心律失常的活性分子和有效的肿瘤抑制剂。
    Lidocaine hydrochloride
  • HY-14654R
    Aspirin (Standard)

    阿司匹林(标准品)

    Inhibitor 99.85%
    Aspirin (Standard) 是 Aspirin 的分析标准品。本产品用于研究及分析应用。Aspirin (Acetylsalicylic Acid) 是一种口服有效的不可逆的环氧合酶 COX-1COX-2 抑制剂,IC50 分别为 5 和 210 μg/mL. Aspirin 诱导细胞凋亡 (apoptosis)。Aspirin 可抑制 NF-κB 的活化。Aspirin 还抑制血小板前列腺素合成酶 (prostaglandin synthetase),可预防冠状动脉和脑血管血栓形成。
    Aspirin (Standard)
  • HY-N0652
    2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside

    2,3,5,4-四羟基二苯乙烯葡萄糖苷

    Inhibitor 99.91%
    2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside 是从蓼科植物物种的根里分离出来的,能够抑制5-HETE、HHT 和 thromboxane B2 的形成。2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside 具有降血压、抗衰老、抗炎、降血脂、心脏保护和神经保护作用。
    2,3,5,4'-Tetrahydroxystilbene 2-O-β-D-glucoside
  • HY-N0044
    Ginsenoside Re

    人参皂苷 Re

    Inhibitor 99.22%
    Ginsenoside Re (Ginsenoside B2) 是一种 Panax notoginseng 提取物。Ginsenoside Re 可降低 β-淀粉样蛋白 ()。Ginsenoside Re 还通过抑制 JNKNF-κB 发挥抗炎作用。
    Ginsenoside Re
  • HY-N0220
    Dauricine

    蝙蝠葛碱

    Inhibitor 99.91%
    Dauricine 是存在于 Menispermum dauricum 中的一种双苯异喹啉生物碱,具有抗炎活性。Dauricine 通过抑制 NF-κB 激活,抑制结肠癌细胞的增值、侵袭,并诱导凋亡,且具有剂量依赖性。
    Dauricine
  • HY-B2123
    Lactose

    乳糖

    Inhibitor ≥98.0%
    Lactose 是一种由半乳糖和葡萄糖残基组成的 β-半乳糖苷,是哺乳动物乳汁中主要的碳水化合物。Lactose 是一种常量营养素,也是宿主先天免疫反应的诱导物,具有免疫调节功能。
    Lactose
  • HY-N0298
    Stachydrine

    水苏碱

    Inhibitor ≥98.0%
    Stachydrine 是中国草本植物益母草的主要成分,用于促进血液循环和消除血瘀。Stachydrine 可抑制 NF-κB 信号通路。
    Stachydrine
  • HY-10454
    Delanzomib Inhibitor ≥98.0%
    Delanzomib (CEP-18770) 是一种强效的具有口服活性的蛋白酶体的胰凝乳蛋白酶样活性 (chymotrypsin-like activity of the proteasome) 抑制剂,IC50 为 3.8 nM。Delanzomib 抑制 NF-κB 活性,诱导癌细胞凋亡 (apoptotic),并具有很强的抗血管生成和抗癌活性。
    Delanzomib
  • HY-116035
    Nimbolide

    印苦楝内酯

    Inhibitor 99.79%
    Nimbolide 是可以从印楝 (Azadirachta indica) 中分离得到的一种三萜化合物,具有抗癌和抗增殖活性。Nimbolide 通过抑制 NF-κBCDK4/CDK6 激酶,诱导肿瘤细胞凋亡。Nimbolide 抑制 Wnt、PI3K-Akt、MAPK 和 JAK-STAT 信号通路。
    Nimbolide
  • HY-N0722
    Neochlorogenic acid

    新绿原酸

    Inhibitor 99.77%
    Neochlorogenic acid 是在干果和其他植物中发现的一种天然多酚化合物。Neochlorogenic acid 抑制 TNF-αIL-1β 产生。 Neochlorogenic acid 抑制 iNOSCOX-2 蛋白表达。Neochlorogenic acid 还抑制磷酸化的 NF-κB p65p38 MAPK 活化。
    Neochlorogenic acid
  • HY-B0167A
    Sodium Salicylate

    水杨酸钠

    Inhibitor 99.93%
    Sodium Salicylate (Salicylic acid sodium salt) 抑制 COX-2 活性,抑制作用与转录因子 (NF-κB) 激活无关。Sodium Salicylate 还是一种 S6K 的抑制剂. Sodium Salicylate 是一种 NF-κB 抑制剂,可降低炎症基因的表达,促进老化肌肉的修复。
    Sodium Salicylate
  • HY-17403
    Manidipine dihydrochloride

    盐酸马尼地平

    Inhibitor 99.91%
    Manidipine dihydrochloride 是一种第三代、亲脂性、口服有效且高血管选择性的钙通道 (calcium channel) 拮抗剂 (IC50 = 2.6 nM, 于豚鼠心室细胞中) 与抗高血压剂。Manidipine 能有效降低血压,兼具提高胰岛素敏感度,肾脏保护和抗动脉粥样硬化活性。Manidipine 还发挥出由 NF-κB 介导的抗炎活性以及通过抑制钙通道对多种黄病毒和负链 RNA 病毒具备的抗病毒活性。美尼地平被广泛应用于心血管、代谢性疾病和感染的研究。
    Manidipine dihydrochloride
  • HY-113556
    Sappanone A 99.58%
    Sappanone A 是一种高异黄烷酮,通过调节 Nrf2NF-κB 表现出抗炎作用。Sappanone A 可以减轻卵清蛋白引起的哮喘中的过敏性气道炎症。
    Sappanone A
  • HY-N0498
    Nitidine chloride

    氯化两面针碱

    Inhibitor 99.75%
    Nitidine chloride 是从 Zanthoxylum nitidum (Roxb) DC 中分离得到一种具有抗疟疾活性的化合物。Nitidine chloride 通过多个靶点通路,发挥抗癌活性,如诱导凋亡,抑制 STAT3,DNA 拓扑异构酶 1 和 2A,ERKc-Src/FAK 相关信号通路,具有抗炎活性。Nitidine chloride 通过 MAPKNF-kB 途径抑制 LPS (HY-D1056) 诱导的炎性细胞因子的产生。
    Nitidine chloride
  • HY-N0017
    Bergenin

    岩白菜素

    99.21%
    Bergenin 是一种细胞保护和抗氧化多酚在许多药用植物中发现。Bergenin 具有广泛的保肝、抗炎、免疫调节、抗肿瘤、抗病毒以及抗真菌作用。
    Bergenin
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.